N-Hydroxybenzotriazole is supplied in two principal product forms: anhydrous material and the crystalline monohydrate. The anhydrous form is identified by CAS 2592-95-2, molecular formula C₆H₅N₃O, and molecular weight 135.12 g/mol. The monohydrate, C₆H₅N₃O·H₂O, has a molecular weight of 153.14 g/mol. Commercial release specifications for the anhydrous grade commonly include HPLC purity ≥ 99.0% by area normalization, water content ≤ 0.5% by Karl Fischer titration in accordance with ISO 760 or USP <921>, residue on ignition ≤ 0.1%, and a white to off-white crystalline powder appearance. For the monohydrate, water content is typically controlled at 10.5–12.5%, with the theoretical hydrate water content being 11.7%. Residual solvent limits are assigned under ICH Q3C when the material is used in active pharmaceutical ingredient synthesis, with controls for methanol, ethanol, dichloromethane, and N,N-dimethylformamide at or below the applicable concentration limits for Class 2 solvents. HPLC purity methods reference Ph. Eur. 2.2.46 or USP <621>.

Why Is Water Content Controlled in Anhydrous and Monohydrate Grades?

Water content is not merely a purity parameter; it changes the safety classification, storage behavior, and drying profile of the material. Anhydrous N-Hydroxybenzotriazole can exhibit impact- and friction-sensitive behavior when dried below 1% moisture, and process safety reviews typically require that the anhydrous form be stored in closed, grounded containers and not subjected to mechanical grinding or metal-spatula scraping. The monohydrate grade is therefore preferred for large-scale peptide synthesis campaigns unless the coupling chemistry requires a strongly anhydrous medium. When the monohydrate is introduced into a carbodiimide-mediated coupling in DMF or NMP, the water of hydration can hydrolyze a portion of the active ester and reduce coupling efficiency. For this reason, azeotropic water removal or vacuum drying is sometimes performed, but only with explosion-risk controls in place. Published data for the minimum safe water content across different dryer geometries is limited; batch-scale vacuum drying must be accompanied by differential scanning calorimetry or accelerating rate calorimetry screening before a new drying cycle is introduced.

In Fmoc-based solid-phase peptide synthesis, the compound functions as a racemization-suppressing trapping nucleophile. When a carbodiimide such as N,N’-diisopropylcarbodiimide or N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide activates the carboxyl group, the initially formed O-acylisourea can undergo intramolecular rearrangement to an unreactive N-acylurea or cyclize to an oxazolone that erodes stereochemical integrity. Addition of N-Hydroxybenzotriazole at 1.0–1.2 mol per mol of Fmoc-amino acid shifts the activated intermediate to a benzotriazol-1-yl active ester. The active ester is sufficiently electrophilic for aminolysis but less prone to oxazolone formation. Typical preactivation is conducted at 0–5 °C for 10–15 min in DMF, after which the resin-bound amine is introduced. Coupling completion is monitored by Kaiser or TNBS tests, and double couplings at 60–90 min intervals are common for hindered residues. The compound also supports isolated active ester preparation, enabling HOBt esters to be used as separated intermediates in solution-phase amidation at 20–25 °C.

Carbodiimide trapping chemistry and racemization control in Fmoc-SPPS

Production-scale Fmoc-SPPS operations using automated synthesizers with resin loadings in the 50–100 mmol range require careful control of HOBt particle size and dissolution. The solid is usually dissolved in DMF at 0.3–0.5 M, and the resulting solution is filtered through a 0.2 µm PTFE membrane before delivery to the reaction vessel to prevent nozzle blockage. In microwave-assisted systems, the coupling temperature may be raised to 50–75 °C; under these conditions, some decomposition of HOBt can generate gas and colored by-products, so shorter reaction times and freshly prepared reagent solutions are required. Batch-to-batch variability in HOBt water content is controlled by Karl Fischer release testing because water influences both active ester hydrolysis rate and solubility in anhydrous solvents. For difficult sequences, the HOBt concentration is not increased indefinitely; excess HOBt above 1.5 equivalents can compete with the amino component for the activated carboxyl group and reduce coupling efficiency. When a process is transferred from a laboratory synthesizer to a larger system, the mixing configuration and temperature control must be reassessed because localized overheating in a glass-lined reactor can accelerate degradation of the active ester. Published data for this specific equipment configuration is limited.

In process analytical control, residual HOBt in protected peptide intermediates is quantified by reversed-phase HPLC with UV detection at 254 nm using a C18 column and an acetonitrile/water gradient containing 0.1% trifluoroacetic acid. The limit of quantitation for residual HOBt is typically 0.05% area relative to the main peptide peak. When HOBt is used as a coupling additive, left-over benzotriazole-related impurities can be removed by resin washing with DMF and dichloromethane. Washing efficiency is monitored by UV absorbance at 254 nm in the filtrate. This analytical approach is a standard control in custom peptide manufacturing and is aligned with Ph. Eur. 2.2.46 for HPLC.

Distinct from N-Hydroxybenzotriazole, 1-hydroxy-7-azabenzotriazole (HOAt) contains an additional ring nitrogen at the 7-position. This substitution increases the anchimeric participation of the neighboring nitrogen during aminolysis and is used for N-methylated residues, hindered beta-branched amino acids, and peptide cyclization steps where HOBt-mediated couplings are slow. HOAt is typically handled as a 0.3 M solution and is less stable in long-term storage. Ethyl cyano(hydroxyimino)acetate (Oxyma) is a non-benzotriazole additive selected when process safety reviews restrict benzotriazole derivatives. Oxyma suppresses racemization in carbodiimide couplings at levels comparable to HOBt under many Fmoc-SPPS conditions and is often paired with N,N’-diisopropylcarbodiimide because the by-product diisopropylurea is easily removed. N-Hydroxysuccinimide, by contrast, is used where isolated succinimidyl esters are advantageous for bioconjugation or low-reactive amine coupling; its active esters are generally less reactive than HOBt esters in peptide bond formation. The choice among these additives is governed by coupling kinetics, racemization risk at the C-terminal residue, safety classification, and preparative workflow rather than by a single performance metric. Published comparative rate data for hindered model couplings often use HPLC conversion at 30 min under standardized conditions; such data indicate that HOAt and Oxyma can outperform HOBt for specific systems, but the reported spread across substrate combinations is wide.

When an Anhydrous Grade Replaces the Monohydrate in a Coupling Campaign

The switch from monohydrate to anhydrous N-Hydroxybenzotriazole is not a simple substitution. Anhydrous material dissolves more readily in dry DMF, but its use in a process optimized for the monohydrate can eliminate the limited hydrolysis buffer that may have been tolerated in an existing coupling step. In pharmaceutical peptide synthesis under ICH Q7, the change is treated as a raw-material grade change and requires revalidation of the coupling step using the same HPLC identity and Karl Fischer methods. Vacuum-drying the monohydrate in an agitated filter-dryer can generate fine particles and static charge; the operation should be performed under nitrogen and at a temperature below the dehydration onset rather than by extending drying time at higher temperature. If the process requires a water-free system, the preferred route is direct purchase of the anhydrous grade rather than in-house dehydration, because the latter transfers the safety burden to the manufacturing site. The anhydrous form is typically packaged in double polyethylene liners inside a fiber drum, with net weights from 1 kg to 25 kg; the monohydrate is often supplied in 25 kg drums or paper bags. The label should identify the exact grade, water content range, and storage instruction under a GHS-compliant safety data sheet.

Compatibility Boundaries with Phosphonium and Aminium Coupling Reagents

N-Hydroxybenzotriazole is not limited to carbodiimide protocols. It is used with phosphonium reagents such as benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate and with aminium reagents such as 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate; in these systems the reagent itself contains benzotriazole, and the function of added HOBt changes from active-ester generator to racemization suppressor and base moderator. The addition rate must be controlled because phosphonium and aminium reagents can exotherm on dissolution in DMF; typical solutions are prepared at 0–5 °C with mixing and are used within 2 h. Incompatibility arises with excessively strong bases or with prolonged exposure to primary amines; the active ester can be converted to the corresponding amide or can undergo ring-opening. HOBt should not be combined with sodium nitrite or other nitrosating agents in acidic media, and it is not recommended for use with oxidizing agents such as peroxides or peracids. For solution-phase peptide fragment condensation, the HOBt requirement is often reduced to 0.1–0.5 equivalents when a preformed active ester is isolated. These operational boundaries are applied to prevent yield loss and impurity formation rather than to broaden the processing envelope.

Beyond solid-phase peptide synthesis, N-Hydroxybenzotriazole is used in solution-phase amidation for peptide pharmaceutical intermediates, in protected peptide fragment synthesis, and in the preparation of peptide nucleic acid monomers. In esterification of sterically hindered alcohols, the corresponding HOBt esters are activated toward nucleophilic attack and can be prepared as isolated intermediates; however, the decomposition risk of the anhydrous solid must be considered before scale-up. The compound is not interchangeable with N-hydroxysuccinimide in all active-ester procedures because the benzotriazol-1-yl leaving group is larger and more polar, which affects extraction, crystallization, and removal of the residual leaving group. In custom peptide manufacturing, the combined selection of HOBt grade, coupling reagent, solvent, and washing sequence is therefore treated as a process-specific decision supported by HPLC release data, Karl Fischer water results, and safety screening rather than a fixed additive recommendation.